Back
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Vs. Dyne Therapeutics Industry Stock Comparison
Buy
79
DCF
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund
Last Price:
9.21
Seasonality Move:
4.42%
Buy
66
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Buy
79
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund (DCF)
is a Buy
Is BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund a Buy, Sell or Hold?
- The current BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund [DCF] share price is $9.24. The Score for DCF is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- DCF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DCF Stock Price Chart
What is BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund's stock price today?
-
The BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund share price today is $9.24
The current trend is moderately bullish and DCF is experiencing slight buying pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $34.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
DCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 59.28 | Buy |
| Chaikin Money Flow: | 11876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.15 - 9.21) | Buy |
| Bollinger Bands (100): | (8.91 - 9.19) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 60.64 | Buy |
| Chaikin Money Flow: | 1192325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.99 - 33.51) | Buy |
| Bollinger Bands (100): | (31.49 - 42.59) | Sell |
DCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.21 | Buy |
| 20-day SMA: | 9.19 | Buy |
| 50-day SMA: | 9.17 | Buy |
| 200-day SMA: | 8.81 | Buy |
| 8-day EMA: | 9.21 | Buy |
| 20-day EMA: | 9.2 | Buy |
| 50-day EMA: | 9.15 | Buy |
| 200-day EMA: | 8.81 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.58 | Buy |
| 20-day SMA: | 30.81 | Buy |
| 50-day SMA: | 32.62 | Buy |
| 200-day SMA: | 32.06 | Buy |
| 8-day EMA: | 30.24 | Buy |
| 20-day EMA: | 30.74 | Buy |
| 50-day EMA: | 32.95 | Buy |
| 200-day EMA: | 30.83 | Buy |
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Earnings Growth & DCF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||